Market Cap | 319.38M | P/E | 32.94 | EPS this Y | 6.70% | Ern Qtrly Grth | - |
Income | 20.33M | Forward P/E | 9.72 | EPS next Y | 96.90% | 50D Avg Chg | 20.00% |
Sales | 258.01M | PEG | 0.22 | EPS past 5Y | - | 200D Avg Chg | 30.00% |
Dividend | N/A | Price/Book | 2.15 | EPS next 5Y | 145.80% | 52W High Chg | -9.00% |
Recommedations | 1.00 | Quick Ratio | 0.76 | Shares Outstanding | 54.04M | 52W Low Chg | 74.00% |
Insider Own | 73.80% | ROA | 3.70% | Shares Float | 15.73M | Beta | 0.82 |
Inst Own | 10.28% | ROE | 14.12% | Shares Shorted/Prior | 279.46K/181.10K | Price | 5.93 |
Gross Margin | 50.55% | Profit Margin | 7.88% | Avg. Volume | 47,862 | Target Price | 7.00 |
Oper. Margin | 5.42% | Earnings Date | Nov 9 | Volume | 48,454 | Change | 4.59% |
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Evercore ISI Group | Neutral | Oct 11, 23 |
TD Cowen | Market Perform | Aug 30, 23 |
Canaccord Genuity | Buy | Aug 11, 23 |
Canaccord Genuity | Buy | Apr 4, 23 |
Canaccord Genuity | Buy | Nov 17, 22 |
RBC Capital | Outperform | Nov 11, 22 |
Cowen & Co. | Outperform | Aug 11, 22 |
RBC Capital | Outperform | Aug 11, 22 |
B of A Securities | Buy | Oct 18, 21 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
JACOBSON PAUL F | Chief Executive Offi.. Chief Executive Officer | Mar 31 | Option | 1.35 | 50,000 | 67,500 | 1,526,549 | 04/04/22 |
Varma Saloni S. | Director Director | Mar 23 | Buy | 6.0059 | 9,223 | 55,392 | 24,223 | 03/24/22 |
WHEELER SCOTT | Chief Financial Offi.. Chief Financial Officer | Mar 23 | Option | 1.25 | 90,780 | 113,475 | 126,600 | 03/24/22 |